All Studies

Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants - Withania somnifera (Ashwagandha), Tinospora cordifolia (Giloy) and Ocimum sanctum (Tulsi) - a molecular docking study.

Shree P et al (2022).
J Biomol Struct Dyn.
PubMed:
32851919

In silico screening of hundred phytocompounds of ten medicinal plants as potential inhibitors of nucleocapsid phosphoprotein of COVID-19: an approach to prevent virus assembly.

Researchers aimed to identify potential drug candidates for COVID-19 treatment by screening 100 phytocompounds for their binding affinity to the N-terminal domain of nucleocapsid phosphoprotein of SARS-CoV-2. Molecular docking and simulation techniques were used to study the interaction stability of the best three protein-ligand complexes. The phytocompounds which showed good binding affinity and met drug likeness properties and non-toxicity were identified as potential therapy for COVID-19. Alizarin, aloe-emodin, and anthrarufin were identified as the most promising phytocompounds and can be further tested for use as a potential drug to cure SARS-CoV-2 infection.

Rolta R et al (2021).
J Biomol Struct Dyn.
PubMed:
32851912